Orally administered therapeutic peptide delivery: Enhanced absorption through the small intestine using permeation enhancers

International Journal of Peptide Research and Therapeutics

Volumn 18, Issue 3, 2012, Pages 259-280

  Pillay, Viness ^a   Hibbins, Angus R ^a   Choonara, Yahya E ^a   Du Toit, Lisa C ^a   Kumar, Pradeep ^a   Ndesendo, Valence M K ^b  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b ST JOHN'S UNIVERSITY OF TANZANIA   (Tanzania)

Author keywords

Chitosan; Occludin peptides; Oral administration; Peptide therapeutics; Permeation enhancers; Tight junctions

Indexed keywords

BILE SALT; CALCITONIN; CHITOSAN; CORTICOTROPIN RELEASING FACTOR; DECANOATE SODIUM; EDETIC ACID; ENALAPRIL MALEATE; ENFUVIRTIDE; ENTEROTOXIN; HIRULOG; OCCLUDIN; OMEGA CONOTOXIN MVIIA; PENETRATION ENHANCING AGENT; PEPTIDE DERIVATIVE; PROTEIN ZO1; SODIUM DERIVATIVE; UNCLASSIFIED DRUG;

BANDAGE; CHRONIC PAIN; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG INDICATION; DRUG POTENCY; DRUG PURIFICATION; DRUG SAFETY; DRUG STABILITY; GASTROINTESTINAL TRACT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HYDROLYSIS; HYPERCALCEMIA; HYPERTENSION; MEMBRANE PERMEABILITY; PAGET BONE DISEASE; PATIENT COMPLIANCE; POSTMENOPAUSE OSTEOPOROSIS; PROTEIN DEGRADATION; REVIEW; TIGHT JUNCTION; UNSTABLE ANGINA PECTORIS;

EID: 84867329999     PISSN: 15733149     EISSN: 15733904     Source Type: Journal    
DOI: 10.1007/s10989-012-9299-7     Document Type: Review

References (136)

1. Agyei D, Danquah MK (2001) Industrial-scale manufacturing of pharmaceutical-grade bioactive peptides. Biotechnol Adv 29: 272-277
2. Amasheh S, Meiri N, Gitter AH, Schöneberg T, Mankertz J, Schulzke JD, Fromm M (2002) Claudin-2 expression induces cationselective channels in tight junctions of epithelial cells. J Cell Sci 115:4969-4976
3. Amidi M, Romeijn SG, Borchard G, Junginger HE, Hennink WE, Jiskoot W (2006) Preparation and characterization of proteinloaded N-Trimethyl chitosan nanoparticles as nasal delivery system. J Control Release 111:107-116
4. Ammar HO, Salama HA, El-Nahhas SA, Elmotasem H (2008) Design and evaluation of chitosan films for transdermal delivery of glimepiride. Curr Drug Deliv 5:290-298
5. Andreeva AY, Krause E, Müller E-C, Blasig IE, Utepbergenov DI (2001) Protein kinase C regulates the phosphorylation and cellular localization of occludin. J Biol Chem 276:38480-38486
6. Aungst BJ (2000) Intestinal permeation enhancers. J Pharm Sci 89:429-442
7. Balda MS, Whitney JA, Flores C, González S, Cereijido M, Matter K (1996) Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apicalbasolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134: 1031-1049
8. Balda MS, Flores-Maldinado C, Cereijido M, Matter K (2000) Multiple domains of occludin are involved in regulation of paracellular permeability. J Cell Biochem 78:85-96
9. Baldrick P (2010) The safety of chitosan as a pharmaceutical excipient. Regul Toxicol Pharmcol 56:290-299
10. Bennett RG, Heimann DG, Hamel FG (2009) Degradation of relaxin family peptides by insulin-degrading enzyme. Ann N Y Acad Sci 1160:38-41
11. Bernkop-Schnürch A, Krajicek ME (1998) Mucoadhesive polymers as platforms for peroral peptide delivery and absorption: synthesis and evaluation of different chitosan-EDTA conjugates. J Control Release 50:215-223
12. Boonyo W, Junginger HE, Waranuch N, Polnok A, Pitaksuteepong T (2007) Chitosan and trimethyl chitosan chloride (TMC) as adjuvants for inducing immune response in mice following nasal administration. J Control Release 121:168-175
13. Boot RG, Blommaart FC, Swart E, van der Ghauharali-Vlugt K, Bijl N, Moe C, Place A, Aerts JMFG (2001) Identification of a novel acidic mammalian chitinase distinct from chitotriosidase. J Biol Chem 276:6770-6778
14. Boothby LA, Doering PL, Kipersztok S (2004) Bioidentical hormone therapy: a review. Menopause 11:356-367
15. Brandner JM (2009) Tight junctions and tight junction proteins in mammalian epidermis. Eur J Pharm Biopharm 72:289-294
16. Bray BL (2003) Large-scale manufacture of peptide therapeutics by chemical synthesis. Nat Rev Drug Discov 2:587-593
17. Cafaggi S, Russo E, Stefani R, Parodi B, Caviglioli G, Sillo G, Bisio A, Aiello C, Viale M (2011) Preparation, characterisation, and preliminary antitumor activity evaluation of a novel nanoparticulate system based on a cisplatin-hyaluronate complex and Ntrimethyl chitosan. Invest New Drugs 29:443-455
18. Campion JM, Maricic MJ (2003) Osteoporosis in men. Am Fam Physician 67:1521-1526
19. Cevher E, Sensoy D, Taha MAM, Abramam A (2008) Effect of thiolated polymers to textural and mucoadhesive properties of vaginal gel formulations prepared with polycarbophil and chitosan. AAPS PharmSciTech 9:953-965
20. Chen Y-H, Lu Q, Goodenough DA, Jeansonne B (2002) Nonreceptor tyrosine kinase c-Yes interacts with occludin during tight junction formation in canine kidney epithelial cells. Mol Biol Cell 13:1227-1237
21. Chen F, Zhang ZR, Huang Y (2007) Evaluation and modification of N-Trimethyl chitosan chloride nanoparticles as protein carriers. Int J Pharm 336:166-173
22. Chen F, Zhang Z-R, Yuan F, Qin X, Wang M, Huang Y (2008) In vitro and in vivo study of N-Trimethyl chitosan nanoparticles for oral protein delivery. Int J Pharm 249:226-233
23. Chen EYT, Yang N, Quinton PM (2010) A new role for bicarbonate in mucus formation. Am J Physiol Lung Cell Mol Physiol 299:L542-L549
24. Cheng W, Lim L-Y (2008) Comparison of reversible and nonreversible aqueous-soluble lipidized conjugates of Salmon calcitonin. Mol Pharm 5:610-621
25. Cheng W, Lim L-Y (2010) Deign, synthesis, characterisation and in vivo activity of a novel salmon calcitonin conjugate containing a novel PEG-lipid moiety. J Pharm Pharmacol 62:296-304
26. Chervenak J (2009) Bioidentical hormones for maturing woman. Maturitas 64:86-89
27. Citi S (1992) Protein kinase inhibitors prevent junction dissociation induced by low extracellular calcium in MDCK epithelial cells. J Cell Biol 117:169-178
28. Cone RA (2009) Barrier properties of mucus. Adv Drug Deliv Rev 61:75-85
29. Copeman M, Matuz J, Leonard AJ, Pearson JP, Dettmar PW, Allen A (1994) The gastroduodenal mucus barrier and its role in protection against luminal pepsins: the effect of 16,16 dimethyl prostaglandin E2, carbopol-polyacrylate, sucralfate and bismuth subsalicylate. J Gastroenterol Hepatol 9:S55-S59
30. Cordenonsi M, D'Atri F, Hammar E, Parry DA, Kendrick-Jones J, Shore D, Citi S (1999) Cingulin contains globular and coiled-coil domains and interacts with ZO-1, ZO-2, ZO-3, and myosin. J Cell Biol 147:1569-1582
31. Davis SS, Illum L, Hinchcliffe M (2001) Gastrointestinal transit of dosage forms in the pig. J Pharm Pharmacol 53:33-39 de Britto D, Filho SPC, Assis OBG (2011) Role of the alkyl moiety and counter ions on the thermal stability of chitosan derivatives. J Appl Polym Sci 121:815-822
32. Decaffmeyer M, Thomas A, Brasser R (2008) Les medicaments peptidiques: mythe ou réalité? Biotechnol Agron Soc Environ 12:255-263
33. Degim T, Celebi N (2007) Controlled delivery of peptides and proteins. Curr Pharm Des 13:99-177
34. Deli MA (2009) Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery. Biochim Biophys Acta 1788:892-910
35. Di Colo G, Burgalassi S, Zambito Y, Monti D, Chetoni P (2004) Effects of different N-Trimethyl chitosans on in vitro/in vivo ofloxacin transcoreneal permeation. J Pharm Sci 93:2851-2862
36. Domard A, Rinaudo M, Terrassin C (1986) New methods for the quaternization of chitosan. Int J Biol Macromol 8:105-107
37. du Plessis LH, Lubbe J, Strauss T, Kotzé AF (2010) Enhancement of nasal and intestinal calcitonin delivery by the novel PheroidTM fatty acid based delivery system, and by N-Trimethyl chitosan chloride. Int J Pharm 385:181-186
38. Fadda HM, Basit AW (2005) Dissolution of pH responsive formulations in media resembling intestinal fluids: bicarbonate versus phosphate buffers. J Drug Deliv Sci Technol 15:273-279
39. Fadda H, Basit AW (2007) Drug solubility in human jejunal fluids and physiologically relevant media: relative importance of buffer composition and intestinal surfactants. AAPS J 9:T2033
40. Fasano A (2008) Physiological, pathological, and therapeutic implication of zonulin-mediated intestinal barrier modulation: living on the edge of the wall. Am J Pathol 172:1243-1252
41. Fasano A, Uzzau S (1997) Modulation of intestinal tight junctions by zonula occludins toxin permits enteral administration of insulin and other macromolecules in an animal model. J Clin Invest 99:1158-1164
42. Fasano A, Baudry B, Pumplin DW, Wasserman SS, Tall BD, Ketley JM, Kaper JB (1991) Vibrio cholera produces a second enterotoxin, which affects intestinal tight junctions. Proc Nat Acad Sci USA 88:5242-5246
43. Fetih G, Habib F, Okada N, Fujita T, Attia M, Yamamoto A (2005) Nitric oxide donors can enhance the intestinal transport and absorption of insulin and [Asu1,7]-eel calcitonin in rats. J Control Release 106:287-297
44. Fetih G, Habib F, Okada N, Fujita T, Attia M, Yamamoto A (2006) Colon-specific delivery and enhanced colonic absorption of [Asu1,7]-eel calcitonin using chitosan capsules containing various additives in rats. J Drug Target 14:165-172
45. Ferrer-Miralles N, Domingo-Espín J, Corchero JL, Vázquez E, Villaverde A (2009) Microbial factories for recombinant pharmaceuticals. Microb Cell Fact 8:17-25
46. Florea BI, Thanou M, Junginger HE, Borchard G (2006) Enhancement of bronchial octreotide absorption by chitosan and Ntrimethyl chitosan shows linear in vitro/in vivo correlation. J Control Release 110:353-361
47. Fujita K, Katahira J, Horiguchi Y, Sonoda N, Furuse M, Tsukita S (2000) Clostridium perfringens enterotoxin binds to the second extracellular loop of claudin-3, a tight junction integral membrane protein. FEBS Lett 476:258-261
48. Furuse M, Tsukita S (2006) Claudins in occluding junctions of humans and flies. Trends Cell Biol 16:181-188
49. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S (1993) Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123:1777-1788
50. Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S (1994) Direct association of occludin with ZO-1 and its possible involvement in the localization of occludin at tight junctions. J Cell Biol 127:1617-1626
51. Gaserød O, Jolliffe IG, Hampson FC, Dettmar PW, Skjak-Braek G (1998) The enhancement of the bioadhesive properties of calcium alginate gel beads by coating with chitosan. Int J Pharm 175:237-246
52. George M, Abraham TE (2006) Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan-A review. J Control Release 114:1-14
53. Giuliani A, Pirri G, Nicoletto SF (2007) Antimicrobial peptides: an overview of a promising class of therapeutics. Cent Eur J Biol 2:1-33
54. González-Mariscal L, Tapia R, Chamorro D (2008) Crosstalk of tight junction components with signalling pathways. Biochim Biophys Acta 1778:729-756
55. Groschwitz KR, Hogan SP (2009) Intestinal barrier function: molecular regulation and disease pathogenesis. Clin Rev Allergy Immunol 124:3-20
56. Guichard G (2004) Du peptide à I'analogue peptidique: strategies de stabilisation de la conformation active, amelioration du profil pharmacocinétique (cyclisation, acides amines non naturels, mimes de repliement, modification du squelette); Du peptide naturelau medicament (Atelier de Formation Inserm 150)
57. Guo X-X, He W, Wang X-Q, Hu X-M (2011) Preparation and efficacy and of tumor vascular-Targeted doxorubicin cationic liposomes coated by N-Trimethyl chitosan. J Appl Polym Sci 121:2149-2156
58. Guzmán F, Barberis S, Illanes A (2006) Peptide synthesis: chemical or enzymatic. Electron J Biotechnol 10:279-314
59. Hamazaki Y, Itoh M, Sasaki H, Furuse M, Tsukita S (2002) Multi-PDZ domain protein 1 (MUPP1) is concentration at tight junctions through its possible interactions with claudin-1 and junctional adhesion molecules. J Biol Chem 277:455-461
60. Hammal JH, Stander M, Kotzé AF (2002) Effect of the degree of quarterization of N-Trimethyl chitosan chloride on absorption enhancement: in vivo evaluation in rat nasal epithelia. Int J Pharm 232:235-242
61. Hammal JH, Schultz CM, Kotzé AF (2003) N-Trimethyl chitosan chloride: optimum degree of quaternization for drug absorption enhancement across epithelial cells. Drug Dev Ind Pharm 29: 161-172
62. Hanna PC, Wieckowski EU, Mietzner TA, McClane BA (1992) Mapping of functional regions of clostridium perfringens type A enterotoxin. Infect Immun 60:2114-2210
63. Hartl D, Hua He C, Koller B, Da Silva CA, Homer R, Lee CG, Elias JA (2008) Acidic mammalian chitinase is secreted via an ADAM17/epidermal growth factor receptor-dependent pathway and stimulates chemokine production by pulmonary epithelial cells. J Cell Biol 283:33472-33482
64. Haskins J, Gu L, Wittchen ES, Hibbard J, Stevenson BR (1998) ZO-3, a novel member of the MUGUK protein family found at the tight junction, interacts with ZO-1 and occludin. J Cell Biol 141:199-208
65. Hickey M, Davis SR, Sturdee DW (2005) Treatment of menopausal symptoms. Dtsch Apoth ZTG 134:23-31
66. Hochman J, Artursson P (1994) Mechanisms of absorption enhancement and tight junction regulation. J Control Release 29:253-267
67. Hruby VJ (2002) Designing peptide receptor agonists and antagonists. Nat Rev Drug Discov 1:847-858
68. Hsiao AY (2011) 3D spheroid culture systems for metastatic prostate cancer dormancy studies and anti-cancer therapeutics development. Biomedical Engineering Events. http://www.bme.umich. edu/about/events.php?query=past. Accessed September 26, 2011
69. Hummel G, Reineke U, Reimer U (2006) Translating peptides into small molecules. Mol BioSyst 2:499-508
70. Ibekwe VC, Fadda HM, Parsons GE, Basit AW (2006) A comparative in vitro assessment of the drug release performance of pHresponsive polymers for ileo-colonic drug delivery. Int J Pharm Sci 308:52-60
71. Ibekwe VC, Fadda HM, McConnell EL, Khela MK, Evans DF, Basit AW (2008) Interplay between intestinal pH, transit time and feed status on the in vivo performance of pH responsive ileo-colonic release system. Pharm Res 25:1828-1835
72. Itoh M, Furuse M, Morita K, Kubota K, Saitou M, Tsukita S (1999) Direct binding of three junction-Associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147:1351-1363
73. Jantratid E, Janssen N, Reppas C, Dressman JB (2008) Dissolution media simulating conditions in the proximal human gastrointestinal tract: an update. Pharm Res 25:1663-1676
74. Jintapattanakit A, Mao S, Kissel T, Junyaprasert VB (2008) Physicochemical properties and biocompatibility of N-Trimethyl chitosan: effect of quaternization and dimethylation. Eur J Pharm Biopharm 70:563-571
75. Jintapattanakit A, Junyaprasert VB, Kissel T (2009) The role of mucoadhesion of trimethyl chitosan and PEGylated trimethyl chitosan nanocomplexes in insulin uptake. J Pharm Sci 98:4818-4830
76. Johnson L (2005) Asymmetry at the molecular level in biology. Eur Rev 2:77-95
77. Jones CF, Grainger DW (2009) In vitro assessments of nanomaterial toxicity. Adv Drug Deliv Rev 61:438-456
78. Kavimandan NJ, Peppas NA (2008) Confocal microscopic analysis of transport mechanisms of insulin across the cell monolayer. Int J Pharm 354:143-148
79. Kean T, Thanou M (2010) Biodegradation, biodistribution and toxicity of chitosan. Adv Drug Deliv Rev 62:3-11
80. Kean T, Roth S, Thanou M (2005) Trimethylated chitosan as nonviral gene delivery vectors: cytotoxicity and transfection efficiency. J Control Release 103:643-653
81. Kerss S, Allen A, Garner A (1982) A simple method for measuring the thickness of the mucus gel layer adherent to rat, frog and human gastric mucosa: influence of feeding, prostaglandin, N-Acetylcysteine and other agents. Clin Sci 63:187-195
82. Kondoh M, Masuyama A, Takahashi A, Asano N, Mizuguchi H, Koizumi N, Fujii M, Hayakawa T, Horiguchi Y, Watanbe Y (2005) A novel strategy for the enhancement of drug absorption using a claudin modulator. Mol Pharmacol 67:749-756
83. Kondoh M, Yoshida T, Kakutani H, Yagi K (2008) Targeting tight junction proteins-significance for drug development. Drug Discov Today 13:180-186
84. Kotzé AF, Thanou M, Lueben, de Boer AG, Verhoef JC, Junginger HE (1999) Effect of the degree of quaternization of N-Trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). Eur J Pharm Biopharm 47:269-274
85. Ladner RC, Sato AK, Gorzelany J, De Souza M (2004) Phage display-derived peptides as therapeutic alternatives to antibodies. Drug Discov Today 9:525-529
86. Lennernäs H, Abrahamsson B (2005) The use of biopharmaceutic classification of drugs in drug discovery and development: current status and future extension. J Pharm Pharmacol 57: 273-285
87. Lindmark T, Kimura Y, Artursson P (1998) Absorption enhancement through intracellular regulation of tight junction permeability by medium chain fatty acids in Caco-2 cells. J Pharmacol Exp Ther 284:362-369
88. Lindmark T, Nikkilä T, Artursson P (1995) Mechanisms of absorption enhancement by medium chain fatty acids in intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 275:958-964
89. Loffet A (2002) Peptide as drugs: is there a market? J Pept Sci 8:1-7
90. MacLennan AH (2008) Hormone replacement therapy: a 2008 perspective. Obstet Gynaecol Reprod Med 19:13-18
91. Mao S, Shuai X, Unger F, Wittmar M, Xie X, Kissel T (2005) Synthesis. Characterization and cytotoxicity of poly(ethylene glycol)-graft-Trimethyl chitosan block copolymers. Biomaterials 26:6343-6356
92. Martins AF, Piali JF, Schuquel ITA, Rubira AF, Muniz EC (2011) Polyelectrolyte complexes of chitosan/heparin and N,N,N-Trimethyl chitosan/heparin obtained at different pH: I. Preparation, characterization, and controlled release of heparin. Colloid Polym Sci 289:1133-1144
93. Masuyama A, Kondoh M, Seguchi H, Takahashi A, Harada M, Fujii M, Mizuguchi H, Horiguchi Y, Watanabe Y (2005) Role of N-Terminal amino acids in the absorption-enhancing effects of the C-Terminal fragment of Clostridium perfringens enterotoxin. J Pharmacol Exp Ther 314:789-795
94. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE (1996) Occludin is a functional component of tight junction. J Cell Sci 109:2287-2298
95. McConnell EL, Fadda HM, Basit AW (2008) Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm 364:213-226
96. McGregor DP (2008) Discovering and improving novel peptide therapeutics. Curr Opin Pharmacol 8:616-619
97. Meaney CM, O'Driscoll CM (2000) A comparison of the permeation enhancement potential of simple bile salt and mixed bile salt: fatty acid micellar systems using the CaCo-2 cell culture model. Int J Pharm 207:21-30
98. Millner RWJ, Lockhart AS, Bird H, Alexiou C (2009) A new hemostatic agent: initial life-saving experience with Celox (chitosan) in cardiothoracic surgery. Ann Thorac Surg 87:e13-e14
99. Morishita M, Peppas NA (2006) Is the oral route possible for peptide and protein drug delivery. Drug Discov Today 11:905-910
100. Morita K, Furuse M, Fujimoto K, Tsukita S (1999) Claudin multigene family encoding four-Transmembrane domain protein components of tight junction strands. Proc Natl Acad Sci U S A 96: 511-516
101. Mourya VK, Inamdar NN (2009) Trimethyl chitosan and its applications in drug delivery. J Mater Sci Mater Med 20:1057-1079
102. Muranishi S (1990) Absorption enhancers. Crit Rev Ther Drug Carrier Syst 7:1-33
103. Nusrat A, Brown GT, Tom J, Drake A, Bui TTT, Quan C, Mrsny RJ (2005) Multiple protein interactions involving proposed extracellular loop domains of the tight junction protein occludin. Mol Biol Cell 16:1725-1734
104. Oberle RL, Das H (1994) Variability in gastric pH and delayed gastric emptying in Yucatan miniature pigs. Pharm Res 11:592-594
105. Oyston PCF, Fox MA, Richards SJ, Clark GC (2009) Novel peptide therapeutics for treatment of infections. J Med Microbiol 58:977-987
106. Paranjpe PV, Sinko PJ (2002) Overcoming paracellular tissue barriers for drug delivery. Pharm News 9:381-395
107. Paris L, Tonutti L, Vannini C, Bazzoni G (2008) Structural organization of tight junctions. Biochim Biophys Acta 1778: 646-659
108. Pichereau C, Allary C (2005) Therapeutic peptides under the spotlight. EBR (Winter issue) 88-91
109. Polnok A, Borchard G, Verhoef JC, Sarisuta N, Junginger HE (2004) Influence of methylation process on the degree of quaternization of N-Trimethyl chitosan chloride. Eur J Pharm Biopharm 57:77-83
110. Powell DW (1987) Ion and water transport in the intestine. In: Andreoli TE, Schultz SG (eds) Physiology of membrane disorders, 2nd edn. Plenum, New York, pp 559-596
111. Quattrocchi E, Kourlas Helen (2004) Teriparatide: a review. Clin Ther 26:841-854
112. Ranfeild J (2006) Center for devices and radiological health (CDRH)'s approval of Celox topical hemostatic granules as a medical device (K061079). Docstoc. http://www.docstoc.com/docs/100104805/K090780. Accessed 10 July 2010
113. Renkema GH, Boot RG, Muijsers AO, Donker-Koopman WE, Aerts JMFG (1995) Purification and characterization of human chitotriosidase, a navel member of the chitinase family of proteins. J Biol Chem 270:2198-2202
114. Roberts GAF (1992) Chitin chemistry. The MacMillan Press, London, pp 1-110, 274-315
115. Rubas W, Cromwell MEM, Shahrokh Z, Villagran J, Nguyen T-N, Wellton M, Nguyen T-N, Mrsny RJ (1996) Flux measurements across Caco-2 monolayers may predict transport in human large intestinal tissue. J Pharm Sci 85:165-169
116. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S (1997) Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137:1393-1401
117. Salama NN, Eddington ND, Fasano A (2006) Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev 58:15-28
118. Sandri G, Rossi S, Bonferoni MC, Ferrari F, Zambito Y, Di Colo G, Caramella C (2005) Buccal penetration enhancement properties of N-Trimethyl chitosan: influence of quaternization degree on absorption of high molecular weight molecule. Int J Pharm 297:16-155
119. Sandzen B, Blom H, Dahlgren S (1988) Gastric mucus gel layer thickness measured by direct light microscopy. An experimental study in the rat. Scand J Gastroenterol 23:1160-1164
120. Sato AK, Viswanathan M, Kent RB, Wood CR (2006) Therapeutic peptides: technological advances driving peptides into development. Curr Opin Biotechnol 17:638-642
121. Sayin B, Somavarapu S, Li XW, Thanou M, Sesardic D, Alpar HO, Senel S (2008) Mono-N-carboxymethyl chitosan (MCC) and Ntrimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Int J Pharm 363:139-148
122. Schiller C, Frohlich CP, Geissman T, Siegmund W, Monnikes H, Hosten N, Weitschies W (2005) Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging. Aliment Pharmacol Ther 22:971-979
123. Schipper NGM, Varum KM, Artursson P (1996) Chitosans as absorption enhancers for poorly absorbable drugs. 1: Influence of molecular weight and degree of acetylation on drug transport across human intestinal epithelial (Caco-2) cells. Pharm Res 13:1686-1692
124. Schipper NGM, Varum KM, Stenberg P, Ocklind G, Lennernas H, Artursson P (1999) Chitosans as absorption enhancers of poorly absorbable drugs 3: influence of mucus on absorption enhancement. Eur J Pharm Sci 8:335-343
125. Serra L, Doménech J, Peppas N (2009) Engineering design and molecular dynamics of mucoadhesive drug delivery systems as targeting agents. Eur J Pharm Biopharm 71:519-528
126. Shah RB and Khan MA (2004) Regional permeability of salmon calcitonin in isolated rat gastrointestinal tracts: transport mechanism using Caco-2 cell monolayer. AAPS J 6:36-40
127. Shao Z, Li Y, Chermak T, Mitra A.K. (1994) Cyclodextrins as Mucosal absorption promoters of insulin. II. Effects of b-cyclodextrin derivatives on a-chymotryptic degradation and enteral absorption of insulin in rats. Pharmaceut Res 11:1174-1179
128. Shepherd R, Reader S, Falshaw A (1997) Chitosan functional properties. Glycoconj J 14:535-542
129. Sheth P, Basuroy S, Li C, Naren AP, Rao RK (2003) Role of phosphatidylinositol 3-kinase in oxidative stress-induced disruption of tight junctions. J Biol Chem 278:49239-49245
130. Simon DB, Lu Y, Choate KA, Velazquez H, Al-Sabban E, Prage M, Casari G, Bettinelli A, Colussi G, Rodriguez-Soriano J, McCredie D, Milford D, Sanjad S, Lifton RP (1999) Paracellin-1, a renal tight junction protein required for paracellular Mg2? resorption. Science 285:103-106
131. Simonelli C (2002) Parathyroid hormone: a new treatment option for osteoporosis. Pharm Ther 27:410-413
132. Smales C, Ellis M, Baumber R, Hussain N, Desmond H, Staddon JM (2003) Occludin phosphorylation: identification of an occludin kinase in brain and cell extracts as CK2. FEBS Lett 545:161-166
133. Snoeck V, Huyghebaert N, Cox E, Vermeire A, Saunders J, Remon JP, Verschooten F, Goddeeris BM (2004) Gastrointestinal transit time of non-disintegrating radio-opaque pellets in suckling and recently weaned piglets. J Control Release 94:143-153
134. Snyman D, Hamman JH, Kotzé JS, Rollings JE, Kotzé AF (2002) The relationship between the absolute molecular weight and the degree of quaternization of N-Trimethyl chitosan chloride. Carbohydr Polym 50:145-150
135. Snyman D, Hamman JH, Kotze AF (2003) Evaluation of the mucoadhesive properties of N-Trimethyl chitosan chloride. Drug Dev Ind Pharm 29:61-69
136. Snyman D, Kotzé AF, Walls TH, Govender T, Lachmann G (2004) Conformational characterization of quaternized chitosan